A new kind of hydrocephalus shunt being developed by Dr. Sam Browd incorporates the latest technologies and promises to dramatically reduce failure rates.
Innovations in enzyme development move researchers in Seattle closer to making precision gene manipulation a therapeutic reality.
Drs. Scott Baker and Eric Chow are on a mission to help survivors of childhood cancer live their healthiest possible lives.
Seattle Children’s lands a major NIH grant to take a multi-pronged look at how the virus that causes Kaposi’s sarcoma spreads and turns cancerous.